Navigation Links
Nucletron, an Elekta Company, Receives U.S. FDA 510(k) Clearance for Esteya Electronic Brachytherapy System for Treating Skin Cancer
Date:10/2/2013

ATLANTA, Oct. 2, 2013 /PRNewswire/ -- Esteya®, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), enabling medical centers in the United States to offer their patients with skin cancer a new treatment option.

Esteya is a new approach for high precision skin cancer treatment. The system relies on a small, high dose rate (HDR) to apply radiation directly to the cancerous site. This direct delivery enables Esteya to focus more therapeutic radiation on the disease target and to minimize radiation to surrounding tissues and organs. Electronic brachytherapy is well-suited for treating skin lesions, such as basal cell or squamous cell carcinoma, achieving a greater than 95 percent cure rate for this technique.

"The interest in Esteya among radiation oncologists during the American Society for Radiation Oncology annual meeting last week in Atlanta was encouraging," John Lapre, EVP Brachytherapy at Elekta commented. "They appreciated the efficient workflow, easy patient set-up, and the short treatment delivery time. They also cited the accessibility of Esteya – due to its compact design and reduced shielding requirements – allowing treatment to occur virtually anywhere patients are seen within the clinic."

The first installations of Esteya in the United States are scheduled to occur in the next few months.

To learn more about Esteya, visit Esteya.com.

Availability of Esteya in target markets is dependent on regulatory admissions and approvals.

For further information, please contact: 
Johan Andersson, Director, Investor Relations, Elekta AB 
Tel: +46 702 1
'/>"/>

SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nucletron, an Elekta company, to Debut New Flexitron Brachytherapy Afterloading Platform at 2013 American Brachytherapy Society Meeting
2. Elekta Announces Monaco 5.0 -- Comprehensive Radiation Treatment Planning Capabilities Brought Together in One System
3. New Elekta Radiation Therapy Technology Takes Weeks Off of Lung Cancer Treatments
4. Switzerlands Hopital Riviera Improves Confidence in Patient Treatment with Elektas Identify Solution
5. Elekta to Spotlight Versa HD System at 2013 ASTRO Annual Meeting
6. Elekta Introduces Groundbreaking Image Guidance Capabilities Integrated with Versa HD Cancer Treatment System
7. Johns Hopkins Kimmel Cancer Center Acquires Elekta Versa HD System
8. Elektas Leksell Gamma Knife Perfexion and Elekta Infinity Place First and Second in 2013 KLAS Radiation Therapy Report
9. Elekta to Exhibit New Versa HD Radiotherapy System at Annual Radiation Physics Conference
10. Odense Universitetshospital tilfører kræftpatienters stereotaktiske strålebehandling næsten tre gange hurtigere med Elektas Versa HD-system
11. Elekta Receives CE Marking for Clarity 4D Monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... , Nov. 18, 2014  NxStage ® ... leading manufacturer of innovative dialysis products , ... Express dialyzer for the in-center, hemodialysis market. ... which is designed to reduce the amount of ... the number of touch point contamination sites.  The ...
(Date:11/18/2014)... N.J. , Nov. 18, 2014 ... 230,000 American women this year who get a ... today announced new resources for case managers to ... and 5—to navigate the myriad physical, emotional and ... resources are available at no cost via the ...
(Date:11/18/2014)... , Nov. 18, 2014  TransCelerate BioPharma ... most recent manuscript on Risk-Based Monitoring (RBM), ... Quality Control Measure in Clinical Trials ," ... Innovation & Regulatory Science  (TIRS) journal. Developed ... with Medidata, the manuscript examines the value ...
Breaking Medicine Technology:NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2New Breast Cancer Resources: Commission For Case Manager Certification Adds Specialty Tools to Case Management Body of Knowledge Online Learning Center 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3
... - Ambrilia,Biopharma Inc. (TSX:AMB), a biopharmaceutical company developing,novel ... and,cancer, held its Annual General and Special Meeting ... novel series of HIV,integrase inhibitors and recent developments ... Chairman of the Board, Mr. Frederic,Porte, and a ...
... 2007 /PRNewswire/ -- Results of the,Option (TOcilizumab ... first multinational Phase III study outside,of Japan, ... 4mg/kg,or 8mg/kg) plus methotrexate achieved a significant ... symptoms of moderate to,severe rheumatoid arthritis (RA) ...
Cached Medicine Technology:Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 2Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 3Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 2Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 3Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 5
(Date:11/21/2014)... (PRWEB) November 21, 2014 Porcelain ... picture-perfect smiles for patients in preparation for the coming ... the fronts of teeth, look completely natural, and can ... situations, veneers are also valued for their ability to ... and can be used on one or several teeth ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Seeking to make it ... Food and Drug Administration on Thursday approved a new ... Hydrocodone -- best known by the brand name Vicodin ... tied to a surge in dangerous addictions across the ... Hysingla ER (hydrocodone bitartrate) is an extended-release tablet to ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Certain genes might prevent ... to a fifth of people with type 2 diabetes, ... been pondered by doctors working with diabetic patients, one ... under the impression that exercise helps decrease insulin resistance ... Pena, director of the Center for Weight Management at ...
(Date:11/21/2014)... 21, 2014 Richard Wolfe, co-founder ... will present advanced benefits administration strategies during the ... HR Leadership Summit. This Game Changer breakout session ... to present cutting-edge solutions and best practices to ... how real-time data exchange between health and welfare ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 Center for ... workshops titled “Massachusetts Insurance Funding for Autism Workshops” to ... navigate their way through the insurance coverage process. ... Massachusetts law and the most effective ways to access ... Dec. 4 from 6-8:00 p.m. at 331 Montvale Ave., ...
Breaking Medicine News(10 mins):Health News:Los Angeles Porcelain Veneers Dentist, Dr. Kevin Sands, Now Creates Picture-Perfect Smiles for Patients for the Holiday Season 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3Health News:Exercise Might Not Help Some Type 2 Diabetics Control Their Blood Sugar 2Health News:Exercise Might Not Help Some Type 2 Diabetics Control Their Blood Sugar 3Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Center for Autism and Related Disorders to Host Massachusetts Autism Insurance Workshops for Parents 2
... tests for liver fibrosis, such as liver stiffness measurement ... chronic hepatitis C, according to a new study in ... Gastroenterological Association (AGA) Institute. "Liver stiffness measurement ... evaluation of hepatitis C, regardless of the stage of ...
... 2020 strategy and its Innovation Union flagship initiative, the ... cooperation activities and how EUREKA could contribute to strengthening ... in the regions. High-level stakeholders and all interested ... conference,s discussions which will have a significant role in ...
... HealthDay Reporter , MONDAY, June 13 (HealthDay News) ... even though most people agree the government-sponsored health insurance program ... survive. Instead, respondents to a Harris ... should be shored up, in part, by lowering the fees ...
... sleep problems with cognitive-behavioral therapy for insomnia can reduce ... presented Tuesday, June 14, in Minneapolis, Minn., at SLEEP ... Sleep Societies LLC (APSS). Results show that about ... reported having suicidal thoughts or wishes during the past ...
... sleep per night is associated with higher ratings for quality ... abstract that will be presented Tuesday, June 14, in Minneapolis, ... Associated Professional Sleep Societies LLC (APSS). Results show that ... hours per night had higher self-reported scores for quality of ...
... By Randy Dotinga HealthDay Reporter , MONDAY, June ... help children solve problems more easily, a goal that can ... study suggests. The research doesn,t suggest that ordinary video ... how a particular type of training can boost brain skills ...
Cached Medicine News:Health News:Noninvasive liver tests may predict hepatitis C patient survival 2Health News:Poll Finds Little Support for GOP Plan to Privatize Medicare 2Health News:Poll Finds Little Support for GOP Plan to Privatize Medicare 3Health News:Cognitive-behavioral therapy for insomnia can reduce suicidal ideation 2Health News:The good life: Good sleepers have better quality of life and less depression 2Health News:Training via Video Game Shown to Boost Kids' Brain Power 2Health News:Training via Video Game Shown to Boost Kids' Brain Power 3
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Ballard trach care HMES and filters, universal use, "Y" filter, CO 2 sampling port...
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
Medicine Products: